Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections-Reference-Cited by-同舟云学术

Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections

Published:2015-04 Issue:13 Volume:65 Page:1324-1336
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bertoli-Avella Aida M.,Gillis Elisabeth,Morisaki Hiroko,Verhagen Judith M.A.,de Graaf Bianca M.,van de Beek Gerarda,Gallo Elena,Kruithof Boudewijn P.T.,Venselaar Hanka,Myers Loretha A.,Laga Steven,Doyle Alexander J.,Oswald Gretchen,van Cappellen Gert W.A.,Yamanaka Itaru,van der Helm Robert M.,Beverloo Berna,de Klein Annelies,Pardo Luba,Lammens Martin,Evers Christina,Devriendt Koenraad,Dumoulein Michiel,Timmermans Janneke,Bruggenwirth Hennie T.,Verheijen Frans,Rodrigus Inez,Baynam Gareth,Kempers Marlies,Saenen Johan,Van Craenenbroeck Emeline M.,Minatoya Kenji,Matsukawa Ritsu,Tsukube Takuro,Kubo Noriaki,Hofstra Robert,Goumans Marie Jose,Bekkers Jos A.,Roos-Hesselink Jolien W.,van de Laar Ingrid M.B.H.,Dietz Harry C.,Van Laer Lut,Morisaki Takayuki,Wessels Marja W.,Loeys Bart L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. TGFβ signalling in context;Massague;Nat Rev Mol Cell Biol,2012

2. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome;Neptune;Nat Genet,2003

3. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome;Habashi;Science,2006

4. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene;Dietz;Nature,1991

5. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2;Loeys;Nat Genet,2005

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The recognition of Loeys–Dietz syndrome as a differential diagnosis;Dermatologica Sinica;2024-09-09

2. Mechanisms of Aortic Dissection: From Pathological Changes to Experimental and In Silico Models;Progress in Materials Science;2024-09

3. Aortic aneurysm: pathophysiology and therapeutic options;MedComm;2024-09

4. The cardiovascular pathologist in the aortic team;Cardiovascular Pathology;2024-09

5. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30